Tags

,

Federal health officials on Friday expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common lung cancer.


from NYT > Business Day http://ift.tt/1iSeOhw
via IFTTThttp://ift.tt/1iSeOhy http://ift.tt/IP98QF

Advertisements